|Allos Therapeutics||United States, Westminster|
|Zai Lab||China, Shanghai|
|Bingshen Investment||China, Shenzhen|
|Sarwa Capital||Egypt, Cairo|
|D.T. Lake Equity Investment||China, Jingan|
|Guardian Media Group||United Kingdom, London|
|Prologis Ventures||United States, San Francisco|
|Two Point O Fund||-|
|Circle Ventures||United States, New York|
|Leadiant Biosciences||United States, Gaithersburg|
|Regiment Capital||United States, Boston|
|Indiegogo||United States, San Francisco|
|Global Health Investment Fund (GHIF)||United States, New York|
|ZAI Lab||China, Shanghai|
|CM-CIC Innovation||France, Paris|
|08 Jun 2017||Malaysia, Kuala Lumpur|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.